Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Pfeffer

Showing results (1-10 of 188) with videos related to

Pageof 19
Sort By:
Circulation|June 19, 1998
ACE inhibitors in acute myocardial infarction: patient selection and timingM A Pfeffer
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|January 3, 2007
Will more complete inhibition of the RAAS with angiotensin receptor blockade improve survival following myocardial infarction?M A Pfeffer
Cardiologia (Rome, Italy)|December 1, 1994
Left ventricular remodeling following myocardial infarctionM A Pfeffer
Evidence-Based Cardiovascular Medicine|December 29, 2005
Rampiril reduced long-term mortality in patients with clinical heart failure following acute MIM A Pfeffer
Texas Heart Institute Journal|October 27, 2001
Tributes to Lewis DexterM A Pfeffer
Herz|December 1, 1993
The Survival and Ventricular Enlargement (SAVE) study: rationale and perspectiveM A Pfeffer
Herz|September 1, 1991
Angiotensin converting enzyme inhibition therapy following myocardial infarction. Rationale for clinical trialsM A Pfeffer
The New England Journal of Medicine|January 12, 1995
ACE inhibition in acute myocardial infarctionM A Pfeffer
Clinical Cardiology|July 11, 2001
Statins: a brief summaryM A Pfeffer
American Heart Journal|September 1, 1993
Angiotensin-converting enzyme inhibition in congestive heart failure: benefit and perspectiveM A Pfeffer
Pageof 19

Showing results (1-10 of 188) with videos related to

Sort By:
Pageof 19
Circulation|June 19, 1998
ACE inhibitors in acute myocardial infarction: patient selection and timingM A Pfeffer
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|January 3, 2007
Will more complete inhibition of the RAAS with angiotensin receptor blockade improve survival following myocardial infarction?M A Pfeffer
Cardiologia (Rome, Italy)|December 1, 1994
Left ventricular remodeling following myocardial infarctionM A Pfeffer
Evidence-Based Cardiovascular Medicine|December 29, 2005
Rampiril reduced long-term mortality in patients with clinical heart failure following acute MIM A Pfeffer
Texas Heart Institute Journal|October 27, 2001
Tributes to Lewis DexterM A Pfeffer
Herz|December 1, 1993
The Survival and Ventricular Enlargement (SAVE) study: rationale and perspectiveM A Pfeffer
Herz|September 1, 1991
Angiotensin converting enzyme inhibition therapy following myocardial infarction. Rationale for clinical trialsM A Pfeffer
The New England Journal of Medicine|January 12, 1995
ACE inhibition in acute myocardial infarctionM A Pfeffer
Clinical Cardiology|July 11, 2001
Statins: a brief summaryM A Pfeffer
American Heart Journal|September 1, 1993
Angiotensin-converting enzyme inhibition in congestive heart failure: benefit and perspectiveM A Pfeffer
Pageof 19